Genprex study links Reqorsa gene therapy to cellular repair pathways in lung cancer patients
GNPX•Genprex said an analysis of 11 lung cancer patients in two clinical trials linked its experimental Reqorsa gene therapy to a shift from an early immune response toward cellular maintenance.
1. Patient analysis
Genprex announced the analysis on Nov. 5, 2026, and presented the findings at the Gerontological Society of America meeting, held Nov. 4-7 in National Harbor, Maryland. The findings support research into Reqorsa’s potential beyond oncology but do not establish an anti-aging benefit.
